Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.

AIDS (London, England) - 2 Jan 2018

Cid-Silva Purificación, Margusino-Framiñán Luis, Balboa-Barreiro Vanesa, Martín-Herranz Isabel, Castro-Iglesias Ángeles, Pernas-Souto Berta, Llibre Josep M, Poveda Eva

Abstract excerpt

: HIV-1 subtype B (54.4%) and subtype F (27.2%) are the most prevalent variants in patients who started antiretroviral therapy including an integrase inhibitor in the last 2 years in Northwest Spain. Virological response rates to antiretroviral therapy based on integrase inhibitor were significantly lower among F subtypes compared with B subtypes at weeks 12 (25.0% vs. 75.0%) and 24 (59.1% vs. 95.0%). Subtype F...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Sustained Virologic Response

Share to Treatment Outcome

Share to Viral Load

Source

Identifiers

PMID: 29112068
DOI: 10.1097/QAD.0000000000001679

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.PMID 29112068Read ↗

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response.Semantic proximity Read ↗

Comparison of the epidemiology, profile of mutations, and clinical response to antiretrovirals among subtypes B and F of the human immunodeficiency virus type 1.Semantic proximity Read ↗

HIV type 1 diversity in northeastern Romania in 200-2001 based on phylogenic analysis of pol sequences from patient failing antiretroviral therapy.Semantic proximity Read ↗

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy.Semantic proximity Read ↗

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.Semantic proximity Read ↗

Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.Semantic proximity Read ↗

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.Semantic proximity Read ↗

Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains.Semantic proximity Read ↗

Phenotypic susceptibility to antiretrovirals among clades C, F, and B/F recombinant antiretroviral-naive HIV type 1 strains.Semantic proximity Read ↗

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.